Premium
HIPAA: On the way out? 42 CFR Part 2 is still here
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32272
Subject(s) - health insurance portability and accountability act , confidentiality , government (linguistics) , accountability , business , internet privacy , protected health information , software portability , political science , computer security , law , health care , health policy , computer science , philosophy , linguistics , hrhis , programming language
The push to eliminate 42 CFR Part 2 (the confidentiality regulation requiring that substance use disorder [SUD] patients consent to release of their treatment records) and replace it with the Health Insurance Portability and Accountability Act (HIPAA) continues, even as the federal government seeks to weaken HIPAA (see ADAW , Jan. 21, Jan. 28). This month, with the deadline for comments on the Request for Information (RFI) to weaken HIPAA, there was no letup from the opponents of 42 CFR Part 2 on hopes for a new bill in Congress. Last year, the American Medical Association was widely credited for stopping such a bill from going forward (see ADAW , Oct. 1, 2018). The reason that the field has fought to keep the regulation is simple: Patients would not want to seek treatment if they couldn't protect their privacy.